Kane Biotech (TSE:KNE) has released an update.
Kane Biotech has finalized the sale of STEM Animal Health to Dechra Veterinary Products for approximately CND $11.5 million, with potential additional earnings based on sales targets. The deal strengthens Kane’s financial position, allowing it to focus on becoming a leader in the wound care and dermatology sectors. A portion of the proceeds will be used to repay Kane’s loan from Pivot Financial, marking a strategic advancement for the company.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
